Ann Miller
Director/Board Member bij INOVIO PHARMACEUTICALS, INC.
Vermogen: 76 951 $ op 31-03-2024
Profiel
Ann Calby Miller is an Independent Director at Inovio Pharmaceuticals, Inc. and Allena Pharmaceuticals, Inc. She previously worked as an Executive Director-Global Marketing at Amgen, Inc., Senior Vice President-Pharmaceutical Services at Eisai Co., Ltd., Vice President-Marketing & Global Marketing at Sanofi SA, and as an Independent Director at Puma Biotechnology, Inc. She received her undergraduate degree from Duke University and her doctorate from Duke University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-11-2023 | 5 544 ( 0.02% ) | 76 951 $ | 31-03-2024 |
Actieve functies van Ann Miller
| Bedrijven | Functie | Begin |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 25-03-2019 |
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 05-10-2020 |
Eerdere bekende functies van Ann Miller
| Bedrijven | Functie | Einde |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 31-12-2021 |
| Sanofi SA | Sales & Marketing | 01-09-2018 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01-01-2011 |
| AMGEN INC. | Sales & Marketing | 01-01-2007 |
Opleiding van Ann Miller
| Duke University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Sanofi SA | Health Technology |
